The ‘Global Infectious Disease Molecular Diagnostics Market Report, Size, Share, Trends, Growth, Analysis, Key Players and Forecast 2023-2028’ by Expert Market Research, gives an extensive outlook of the global infectious disease molecular diagnostics market, assessing based on its segments like product, technology, application, end use, and major regions.
Infectious Disease Molecular Diagnostics Market Size, Trends, Industry Report, Key Player, Major Segments, and Forecast
The key highlights of the report include:
Market Overview (2018-2028)
- Historical Market Size (2021): USD 33.68 billion
- Forecast CAGR (2023-2028): 3.20%
- Forecast Market Size (2027): USD 40.69 billion
|Market Size in 2021||USD 33.68 billion|
|Revenue Forecast in 2027||USD 40.69 billion|
|Growth Rate CAGR||3.20%|
|Major Players||Becton, Dickinson and Company, bioMérieux SA, Qiagen GmbH,F. Hoffmann-La
Roche Ltd, Abbot Laboratories, and Danaher Corporation, among others.
The increased awareness of medicines and early-stage care for infectious diseases is increasing the demand for molecular diagnoses, which will also boost the market growth. New molecular test techniques and platforms, such as real-time PCR platforms, point-of-care molecular testing, and other innovative developments, are gaining public trust and assisting in market growth.
Get a Free Sample Report with Table of Contents- https://www.expertmarketresearch.com/reports/infectious-disease-molecular-diagnostics-market/requestsample
In the forecast period, factors such as a lack of skilled labour and high infrastructure costs may pose challenges to the growth of the infectious disease molecular diagnostics market.
Infectious Disease Molecular Diagnostics Industry Definition and Major Segments
Infectious disease molecular diagnostics are tests that are used to find new strains of infectious diseases as well as identify resistant organisms that are linked to the disease, and disease severity. These tests begin with the collection of DNA or RNA from human cells, which is then analysed to determine the sequence that could be the cause of the onset of a specific infectious disease. Gene amplification by PCR is the most commonly used molecular diagnostic method in clinical laboratories.
Read Full Report with Table of Contents- https://www.expertmarketresearch.com/reports/infectious-disease-molecular-diagnostics-market
Based on product, the market is divided into:
On the basis of technology, the market is segmented into:
- Polymerase Chain Reaction (PCR)
- In Situ Hybridisation
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Chips and Microarrays
- Mass Spectrometry
- Transcription Mediated Amplification
Based on application, the market is divided into:
- Respiratory Diseases
- Gastrointestinal Tract Infections
- Sexually Transmitted Infections
- Drug Resistance Diseases
On the basis of end use, the market is segmented into:
- Diagnostic Laboratories
- Research Institutes
Based on region, the market is segmented into:
- North America
- Latin America
- Middle East and Africa
Infectious Disease Molecular Diagnostics Market Trends
Based on product, the reagent segment of the infectious disease molecular diagnostics market is leading because it aids in rapid and sensitive amplification of RNA and DNA, allowing for faster results by speeding up processing. It is expected to continue to dominate the market in the future. This is because point-of-care testing techniques are becoming more popular.
As a result of the vast prevalence of infectious diseases, an increasing geriatric population, and an increase in medicine expenditure, Asia Pacific accounts for a significant portion of the infectious disease molecular diagnostics market. In the Asia Pacific region, advanced technologies are increasingly being adopted, and healthcare infrastructure is improving. Healthcare providers and governments are increasing the use of specialised diagnostic techniques, which is ultimately contributing to the market’s growth.
Key Market Players
The major players in the infectious disease molecular diagnostics market report are:
- Becton, Dickinson and Company
- bioMérieux SA
- Qiagen GmbH
- Hoffmann-La Roche Ltd
- Abbott Laboratories
- Danaher Corporation
The report studies the latest updates in the market, along with their impact across the market. It also analyses the market demand, together with its price and demand indicators. The report also tracks the market on the bases of SWOT and Porter’s Five Forces Models.
Expert Market Research (EMR) is a leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium-scale enterprises.
EMR customises syndicated reports according to client’s requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate, and actionable industry intelligence so that they may formulate informed, effective, and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Frara Prih, Corporate Sales Specialist – U.S.A.
Email: [email protected]
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA